Vanda Pharmaceuticals Executive and Leadership Team

Mihael Polymeropoulos, the President, Chief Executive Officer & Chairman at Vanda Pharmaceuticals, directs the overarching corporate strategy and research vision. Polymeropoulos architects the integration of genetics and genomics into drug discovery processes to ensure the development of novel therapeutic approaches. By aligning clinical trial objectives with long-term commercial goals, the President, Chief Executive Officer & Chairman maintains a focus on high-impact medical innovation. Mihael Polymeropoulos oversees the expansion of operations across North America, Europe, and Asia, ensuring consistent growth in the competitive biopharmaceutical landscape. This leadership role involves constant collaboration with the Board to refine the company's mission of improving patient lives. Through rigorous oversight of research and development pipelines, the President, Chief Executive Officer & Chairman secures the company's position as a leader in specialized pharmaceutical delivery methods and advanced medical research.

Paul Jones, the Chief Financial Officer at Vanda Pharmaceuticals, manages the fiscal health and capital allocation strategies required for sustained biopharmaceutical development. Jones monitors global financial performance across North American, European, and Asian markets to ensure operational efficiency. By analyzing market trends and research expenditures, the Chief Financial Officer provides the necessary data to support drug discovery initiatives. Paul Jones coordinates with executive leadership to optimize resource distribution, directly impacting the speed of clinical trials. This role involves maintaining strict compliance with international financial regulations while driving revenue growth through strategic investment. As the Chief Financial Officer, Jones ensures the company possesses the liquidity to advance medical research projects. Through precise financial planning and risk management, the Chief Financial Officer supports the long-term viability of the company's innovative pharmaceutical portfolio.

Kevin Moran, the Senior Vice President, Chief Financial Officer and Treasurer at Vanda Pharmaceuticals, directs treasury operations and capital structure management. Moran oversees liquidity, cash management, and investment strategies to fund the company's extensive research and development pipeline. By managing the balance sheet, the Senior Vice President, Chief Financial Officer and Treasurer ensures the financial stability required for global expansion across North America, Europe, and Asia. Kevin Moran collaborates with the executive team to evaluate the financial feasibility of new drug delivery methods and therapeutic approaches. This leadership position involves mitigating financial risks associated with international pharmaceutical operations. Through the oversight of treasury functions, the Senior Vice President, Chief Financial Officer and Treasurer enables the company to pursue aggressive medical research goals. Moran maintains the fiscal discipline necessary to support the company's mission of creating innovative medicines for diverse health conditions.

Joakim Wijkstrom, the Senior Vice President. Chief Marketing Officer. Executive Leadership Team at Vanda Pharmaceuticals, drives the commercialization strategies for novel therapeutic products. Wijkstrom architects global marketing campaigns that communicate the value of advanced genomics-based medicines to healthcare providers and patients. By analyzing market dynamics across North America, Europe, and Asia, the Senior Vice President. Chief Marketing Officer. Executive Leadership Team ensures that pharmaceutical offerings reach target populations effectively. Joakim Wijkstrom collaborates with clinical and research teams to align product messaging with the latest medical breakthroughs. This role involves managing brand positioning and market access to maximize the impact of the company's drug portfolio. Through strategic outreach and commercial planning, the Senior Vice President. Chief Marketing Officer. Executive Leadership Team supports the company's growth objectives. Wijkstrom ensures that marketing initiatives remain consistent with the company's commitment to improving patient lives.